Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan

British Journal of Cancer

Volumn 93, Issue 5, 2005, Pages 607-610

  Kurozawa, Y ^a   Ogimoto, I ^b   Shibata, A ^b   Nose, T ^a   Yoshimura, T ^c   Suzuki, H ^d   Sakata, R ^b   Fujita, Y ^b   Ichikawa, S ^b   Iwai, N ^e   Tamakoshi, A ^f  

^a TOTTORI UNIVERSITY   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c FUKUOKA INSTITUTE OF HEALTH AND ENVIRONMENTAL SCIENCES   (Japan)

^d NIIGATA UNIVERSITY   (Japan)

^e Chugoku Occup Health Association   (Japan)

^f NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Coffee; Hazard ratio; Hepatocellular carcinoma; Japan Collaborative Cohort Study (JACC Study)

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER MORTALITY; CANCER RISK; CIGARETTE SMOKING; COFFEE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; EDUCATION; FEMALE; HUMAN; JAPAN; LIVER CELL CARCINOMA; LIVER DISEASE; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICAL ANALYSIS; STATISTICAL MODEL; COHORT ANALYSIS; INCIDENCE; LIFESTYLE; LIVER TUMOR; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK; RISK FACTOR;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; COFFEE; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; JAPAN; LIFE STYLE; LIVER NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS;

EID: 26944498330     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602737     Document Type: Article

References (22)

1. Bulatao-Jayme J, Almero EM, Castro CA, Jardeleza TR, Salamant LA (1982) A case-control dietary study of primary liver cancer risk from aflatoxin exposure. Int J Epidemiol 11: 112-119
2. Corrao G, Lepore AR, Torchio P, Valenti M, Galatola G, D'Amicis A, Arico S, Di Orio F (1994) The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case-control study. Provincial group for the study of chronic liver disease. Eur J Epidemiol 10: 657-664
3. Corrao G, Zambon A, Bagnardi V, D'Amicis A, Klatsky A, Collaborative SIDECIR Group (2001) Coffee, caffeine, and the risk of liver cirrhosis. Ann Epidemiol 11(7): 458-465
4. Gallus S, Tavani A, Negri E, La Vecchia C (2002a) Dose coffee protect against liver cirrhosis? Ann Epidemiol 12: 202-205
5. Gallus S, Bertuzzi M, Tavani A, Bosetti C, Negri E, La Vecchia C, Lagiou P, Trichopoulos D (2002b) Does coffee protect against hepatocellular carcinoma? Br J Cancer 87: 956-959
6. Hasegawa M, Yamada S, Hirayama C (1989) Fasting plasma caffeine level in cirrhotic patients: relation to plasma level of catecholamines and renin activity. Hepatology 10: 973-977
7. Inoue M, Yoshimi I, Sobue T, Tsugane S, For the JPHC Study Group (2005) Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst 96: 293-300
8. Klatsky AL, Armstrong MA (1992) Alcohol, smoking, coffee, and cirrhosis. Am J Epidemiol 136: 1248-1257
9. Klatsky AL, Armstrong MA, Friedman GD (1993) Coffee, tea, and mortality. Ann Epidemiol 3: 375-381
10. Kuper H, Tzonou A, Kaklamani E, Hsieh CC, Lagiou P, Adami HO, Trichopoulos D, Stuver SO (2000) Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer 85: 498-502
11. Kurozawa Y, Ogimoto I, Shibata A, Nose T, Yoshimura T, Suzuki H, Sakata R, Fujita Y, Ichikawa S, Iwai N, Fukuda K, Tamakoshi A (2004) A. dietary habits and risk of death due to hepatocellular carcinoma in a large scale cohort study in Japan. Univariate analysis of JACC study data. Kurume Med J 51: 141-149
12. La Vecchia C, Ferraroni M, Negri E, D'Avanzo B, Decarli A, Levi F, Franceschi S (1989) Coffee consumption and digestive tract cancers. Cancer Res 49: 1049-1051
13. La Vecchia C, Negri E, Cavalieri D'Oro L, Franceschi S (1998) Liver cirrhosis and the risk of primary liver cancer. Eur J Cancer Prevent 7: 315-320
14. La Vecchia C, Negri E, Decarli A, D'Avanzo B, Franceschi S (1988) Risk factors for hepatocellular carcinoma in northern Italy. Int J Cancer 42: 872-876
15. La Vecchia CL, Negri E, Decarli A, Franceschi S (1997) Diabetes mellitus and the risk of primary liver cancer. Int J Cancer 73: 204-207
16. Ohno Y, Tamakoshi A, the JACC Study Group (2001) Japan Collaborative Cohort Study for Evaluation of Cancer Risk Spnsored by Monbusho (JACC Study). J Epidemiol 11: 144-150
17. Shibata A, Ogimoto I, Kurozawa Y, Nose T, Yoshimura T, Suzuki H, Iwai N, Sakata R, Fujita Y, Ichikawa S, Fukuda K, Tamakoshi A, the JACC study group (2003) Past medical history and risk of death due to hepatocellular carcinoma, univariate analysis of JACC Study data. Kurume Med J 50: 109-119
18. Tabor E (1998) Viral hepatitis and liver cancer. In: Pathology of Viral Hepatitis, Goldin RD, Thomas HC, Gerber MA (eds) London: Arnold. 161-177
19. Tanaka K, Hirohata T, Takeshita S, Hirohata I, Koga S, Sugimachi K, Kanematsu T, Ohryohji F, Ishibashi H (1992) Hepatitis B virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma: a case-control study in Fukuoka, Japan. Int J Cancer 51: 509-514
20. Tanaka T, Nishikawa A, Shima H, Sugie S, Shinoda T, Yoshimi N, Iwata H, Mori H (1990) Inhibitory effects of chlorogenic acid, reserpine, polyprenoic acid (E-5166), or coffee on hepatocarcinogenesis in rats and hamsters. Basic Life Sci 52: 429-440
21. Yoshizawa H (2002) Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: protection to other countries in the foreseeable future. Oncology 62(Suppl 1): 8-17
22. Yu MW, Chiu YH, Chiang YC, Chen CH, Lee TH, Santella RM, Chern HD, Liaw YF, Chen CJ (1999) Plasma carotenoids, glutathione S-transferase M1 and T1 genetic polymorphisms, and risk of hepatocellular carcinoma: independent and interactive effects. Am J Epidemiol 149: 621-629